摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-{4-[4-(7-hydroxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione | 874471-23-5

中文名称
——
中文别名
——
英文名称
2-{4-[4-(7-hydroxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione
英文别名
2-(4-(4-(7-hydroxynaphthalen-1-yl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione;desmethyl-MPT;2-[4-[4-(7-Hydroxynaphthalen-1-yl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione
2-{4-[4-(7-hydroxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione化学式
CAS
874471-23-5
化学式
C22H27N5O3
mdl
——
分子量
409.488
InChiKey
DSJDREDLRIFSQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    205 °C (decomp)
  • 沸点:
    604.6±65.0 °C(Predicted)
  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    79.7
  • 氢给体数:
    1
  • 氢受体数:
    6

SDS

SDS:f4b43816f5f87e147804259b93a29c00
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Microfluidic radiosynthesis of [18F]FEMPT, a high affinity PET radiotracer for imaging serotonin receptors
    摘要:
    连续流微流控技术在过去十年中在放射化学中的应用有所增加,特别是用于氟-18标记放射性示踪剂的临床前和临床生产。微流控技术的主要优点是缩短反应时间、降低试剂消耗,这通常会导致增加放射化学产率和快速优化18F标记的反应参数。本文报道了通过微流控放射化学的两步法合成高亲和力的5-羟色胺1A受体部分激动剂[18F]FEMPT(pKi = 9.79; Ki = 0.16 nM)。[18F]FEMPT的孤立放射化学收率约为7%,放射化学和化学纯度均大于98%。最终产品的摩尔活性确定为大于148 GBq/µmol(大于4 Ci/µmol)。
    DOI:
    10.3762/bjoc.13.285
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2 H ,4 H )-1,2,4-triazine as 5-HT 1A R ligands
    摘要:
    5-HT1AR agonist or partial agonists are established drug candidates for psychiatric and neurological disorders. We have reported the synthesis and evaluation of a series of high affinity 5-HT1AR partial agonist PET imaging agents with greater selectivity over α-1AR. The characteristic of these molecules are 3,5-dioxo-(2H,4H)-1,2,4-triazine skeleton tethered to an arylpiperazine unit through an alkyl side chain. The most potent 5-HT1AR agonistic properties were found to be associated with the molecules bearing C-4 alkyl group as the linker. Therefore development of 3,5-dioxo-(2H,4H)-1,2,4-triazine bearing arylpiperazine derivatives may provide high affinity selective 5-HT1AR ligands. Herein we describe the synthesis and evaluation of the binding properties of a series of arylpiperazine analogues of 3,5-dioxo-(2H,4H)-1,2,4-triazine.
    DOI:
    10.1016/j.bmcl.2014.07.048
点击查看最新优质反应信息

文献信息

  • WO2006/83424
    申请人:——
    公开号:——
    公开(公告)日:——
  • Synthesis and in Vivo Validation of [<i>O</i>-Methyl-<sup>11</sup>C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2<i>H</i>-[1,2,4]triazine-3,5-dione:  A Novel 5-HT<sub>1A</sub> Receptor Agonist Positron Emission Tomography Ligand
    作者:J. S. Dileep Kumar、Vattoly J. Majo、Shu-Chi Hsiung、Matthew S. Millak、Kuo-Peing Liu、Hadassah Tamir、Jaya Prabhakaran、Norman R. Simpson、Ronald L. Van Heertum、J. John Mann、Ramin V. Parsey
    DOI:10.1021/jm050725j
    日期:2006.1.1
    Antagonist 5-HT1A PET ligands are available, but an agonist ligand would give more information about signal transduction capacity. Synthesis and in vivo evaluation of [O-methyl-C-11]2-4-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione (10), a potential high affinity (K-i = 1.36 nM) 5-HT1A agonist PET tracer is described. Piperazine 10 is a 5-HT1A agonist with an EC50 comparable to serotonin, based on cAMP formation and GTP(gamma)S binding assays. Radiosynthesis of [C-11]10 has been achieved by reacting 2-4-[4-(7-hydroxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazitle-3,5-dione (9) and [C-11]CH3OTf in 25 +/- 5% (n = 15) yield at the end of synthesis (EOS). The chemical and radiochemical purities of [C-11]10 were > 99% with a specific activity 1500 +/- 300 Ci/mmol (n = 15). PET studies in anesthetized baboon demonstrate [C-11]10 specific binding, in brain regions rich in 5-HTIA receptors. Binding of [C-11]10 was blocked by WAY 100635 and 8-OH-DPAT. The regional brain volumes of distribution (V-T) of [C-11]10 in baboon correlate with [C-11]WAY100635 V-T in baboons. These data provide evidence that [C-11]10 is the first promising agonist PET tracer for the 5-HTIA receptors.
  • Radiolabeled compounds and uses thereof
    申请人:Mann Joseph John
    公开号:US20080138283A1
    公开(公告)日:2008-06-12
    The present invention relates to Radiolabeled Compounds and methods of use thereof for treating or preventing a psychiatric disorder in a subject, for stabilizing the mood of a subject having a mood disorder, or as imaging agents for a serotonin receptor. Compositions comprising an imaging-effective amount of a Radiolabeled Compound are also disclosed.
  • US8168786B2
    申请人:——
    公开号:US8168786B2
    公开(公告)日:2012-05-01
  • [EN] RADIOLABELED COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS RADIOMARQUÉS ET LEURS UTILISATIONS
    申请人:UNIV COLUMBIA
    公开号:WO2009006227A1
    公开(公告)日:2009-01-08
    The present invention relates to Radiolabeled Compounds and methods of use thereof for treating or preventing a psychiatric disorder in a subject, for stabilizing the mood of a subject having a mood disorder, or as an imaging agents for a serotonin receptor. Compositions comprising an imaging-effective amount of a Radiolabeled Compound are also disclosed.
查看更多